This question has been answered by the relevant Government Department.
Question text
Lord Mendelsohn to ask Her Majesty's Government what plans they have (1) to review the treatment options for immune-compromised individuals, and (2) to deploy Bebtelovimab as a treatment for such patients. HL729
Legend for business item text
† Item that is new or altered.
[I] Indicates that the member concerned has
a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.
Main Member
Lord Mendelsohn
Labour
Life peer